Lupin launches generic antidepressant tablets in US

The company has launched its Fluoxetine tablets USP in the strength of 60mg after having received an approval from the United States Food and Drug Administration.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news